KQ Labs
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
An Accelerator Programme at the Francis Crick Institute to support start-ups working at the interface between biomedical and data science.
Investor Profile
KQ Labs has backed more than 6 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Pre Seed, Convertible Note, Seed rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
Stage Focus
- Pre Seed (50%)
- Convertible Note (33%)
- Seed (17%)
Country Focus
- United Kingdom (83%)
- United States (17%)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Biopharma
- Machine Learning
- Artificial Intelligence (Ai)
- Life Science
- Pharmaceutical
- Software
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
